Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Hideaki, Okada"'
Publikováno v:
Thoracic Cancer, Vol 15, Iss 15, Pp 1271-1275 (2024)
Abstract In non‐small‐cell lung cancer, continuous immune‐checkpoint inhibitors (ICIs) beyond progression are often used in clinical practice. On the other hand, there is almost no data on whether the concept of continuous ICIs beyond progressi
Externí odkaz:
https://doaj.org/article/3562e7da0a324b3e95d82fd3898a0ae0
Autor:
Hideaki Okada, Koichi Kitagawa
Publikováno v:
Cancer Medicine, Vol 12, Iss 7, Pp 7904-7910 (2023)
Abstract Background Cisplatin, a first‐generation platinum agent, is used for managing various cancers and is associated with dose‐dependent side effects of hearing impairment and tinnitus. However, the safety of high‐dose cisplatin in hearing
Externí odkaz:
https://doaj.org/article/a33305c88e054b58a7c9ebc5b466b51d
Autor:
Motoko Tachihara, MD, PhD, Akito Hata, MD, Takaaki Tokito, MD, PhD, Satoshi Hara, MD, PhD, Hideaki Okada, MD, Satoru Miura, MD, PhD, Yuki Sato, MD, Eriko Tabata, MD, PhD, Hiroshi Watanabe, MD, PhD, Yusuke Takayama, MD, PhD, Ryo Toyozawa, MD, PhD, Keiichi Ota, MD, PhD, Kazushige Wakuda, MD, PhD, Atsushi Nakamura, MD, PhD, Mototsugu Shimokawa, PhD, Nobuyuki Yamamoto, MD, PhD, Kazuhiko Nakagawa, MD, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100569- (2023)
Introduction: Docetaxel plus ramucirumab could be a promising treatment for chemo-naive elderly patients with NSCLC, but high incidence of febrile neutropenia (FN) is a critical concern. We thus adopted a routine primary prophylactic pegylated-granul
Externí odkaz:
https://doaj.org/article/8ba5db23f12745978f3d1100137cfd60
Autor:
Hiroshi Mayahara, Kazuyuki Uehara, Aya Harada, Keiji Kitatani, Tomonori Yabuuchi, Shuichirou Miyazaki, Takeaki Ishihara, Hiroki Kawaguchi, Hikaru Kubota, Hideaki Okada, Taira Ninomaru, Chihiro Shindo, Akito Hata
Publikováno v:
Radiation Oncology, Vol 17, Iss 1, Pp 1-10 (2022)
Abstract Background Concurrent chemoradiotherapy (CCRT) followed by durvalumab is the standard of care for unresectable locally-advanced non-small cell carcinoma (LA-NSCLC). However, a major concern about administration of durvalumab after CCRT is wh
Externí odkaz:
https://doaj.org/article/529cb1f3ea8446459348acdab30eb089
Autor:
Koichi Kitagawa, Hideaki Okada, Shuichiro Miyazaki, Yohei Funakoshi, Yukinari Sanada, Naoko Chayahara, Hiroshi Mayahara, Masahiko Fujii
Publikováno v:
Cancer Medicine, Vol 10, Iss 21, Pp 7525-7533 (2021)
Abstract Background Although rare, cytomegalovirus (CMV) reactivation can be lethal in patients with cancer. However, the criteria for the prevention of cytomegalovirus reactivation during cancer treatment are unclear. This study aimed to identify fa
Externí odkaz:
https://doaj.org/article/c67d783de08a46d1badf9aa6ec171cbe
Autor:
Seiju MATSUDA, Shogo SUZUKI, Kai YABUMOTO, Hideaki OKADA, Yuki MIMA, Noriaki KIMURA, Kenjiro KIMURA
Publikováno v:
Electrochemistry, Vol 89, Iss 5, Pp 420-426 (2021)
The aim of this study is to observe the spatial inhomogeneity of a rechargeable battery’s electric conductivity distribution. Therefore, we have developed a system that uses the measurement results of a minute magnetic field that leaks from the cel
Externí odkaz:
https://doaj.org/article/eae7a6ec0eb64cf7883cbb439791f734
Publikováno v:
Thoracic Cancer, Vol 12, Iss 6, Pp 746-751 (2021)
Abstract Background Indication for treatment with osimertinib after first/second generation (1/2G) epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI) resistance depends on T790M mutation detected by rebiopsy. The aim of our stu
Externí odkaz:
https://doaj.org/article/ff2967f0561b419b97e11db5a19ced6c
Autor:
Taira Ninomaru, MD, Hideaki Okada, MD, Mika Fujishima, MD, PhD, Kei Irie, PhD, Shoji Fukushima, PhD, Akito Hata, MD
Publikováno v:
JTO Clinical and Research Reports, Vol 2, Iss 3, Pp 100145- (2021)
The spread of next-generation sequencing enables clinicians to identify rare oncogene alterations, including MET exon 14 skipping mutation, in clinical practice for NSCLC. Several tyrosine kinase inhibitors for MET exon 14 skipping mutation such as c
Externí odkaz:
https://doaj.org/article/1ecf4d948d4f4e88a0c38703ea02140e
Autor:
Hideaki Okada, Koichi Kitagawa
Publikováno v:
Cancer Medicine. 12:7904-7910
Cisplatin, a first-generation platinum agent, is used for managing various cancers and is associated with dose-dependent side effects of hearing impairment and tinnitus. However, the safety of high-dose cisplatin in hearing impairment, has not been f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8953949af3e14251c4495d7b414c50b
https://doi.org/10.1002/cam4.5565
https://doi.org/10.1002/cam4.5565
Autor:
Kai Yabumoto, Shogo Suzuki, Seiju Matsuda, Hideaki Okada, Kenjiro Kimura, Yuki Mima, Noriaki Kimura
Publikováno v:
Electrochemistry, Vol 89, Iss 5, Pp 420-426 (2021)
The aim of this study is to observe the spatial inhomogeneity of a rechargeable battery's electric conductivity distribution. Therefore, we have developed a system that uses the measurement results of a minute magnetic field that leaks from the cell
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13bfd2c302724db3eddaa7b1714a1321
https://hdl.handle.net/20.500.14094/90008586
https://hdl.handle.net/20.500.14094/90008586